Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Li (Cindy) Feng is a postdoctoral fellow in the Integrative Tumor Epidemiology Branch.

Li (Cindy) Feng, Ph.D.

Postdoctoral Fellow
Integrative Tumor Epidemiology Branch

NCI Shady Grove | Room 7E226

 240.276.5773
|
li.feng@nih.gov
Current Fellows in the Integrative Tumor Epidemiology Branch

Learn more about the fellows and what they do.

Li (Cindy) Feng, Ph.D., joined DCEG as a postdoctoral fellow in the Integrative Tumor Epidemiology Branch (ITEB) under the mentorship of Rose Yang, Ph.D., M.P.H., senior investigator, ITEB, in July 2024.  Dr. Feng obtained her Ph.D. in nutrition with a focus on epidemiology and quantitative analysis in 2024, and a master's in nutrition specializing in molecular immunology in 2014, both from the University of Maryland, College Park. For her doctoral work, Dr. Feng utilized multi-omics data, advanced statistical models, causal inference, and machine learning to explore modifiable risk factors associated with brain aging and elucidate metabolic pathways in breast cancer survivors. Her overall research aim is to harness precision medicine approaches to develop personalized treatment and prevention strategies for cancer and aging.

In ITEB, Dr. Feng is conducting molecular epidemiologic analyses of breast cancer to examine molecular profiles in breast tumors, adjacent normal tissues, and tumor microenvironment among breast cancer patients in Asian and African populations and to associate the molecular changes with etiologic factors, breast tissue composition, and clinical outcomes.

Email